Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer

This study has been terminated.
(Lack of NK cell expansion in 5/5 patients)
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota Identifier:
First received: April 14, 2010
Last updated: April 14, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2016
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)